The following is a guest article by Taiwan Excellence
For years, healthcare conferences have been dominated by bold promises — sweeping technologies that shine on stage but struggle inside clinical workflows. Inside hospitals, the reality has been far more grounded: pilots that stall, tools that add friction, and “innovations” that fade after the demo.
Meanwhile, health systems face mounting pressure to modernize amid workforce shortages, rising costs, and expanding digital demands and rising patient expectations. AI is no longer theoretical. Adoption is no longer about possibility. It is about integration, security, and scale.
For CIOs and clinical leaders, the question is simple: Can this run inside my hospital?
At HIMSS 2026, the industry may finally be ready to answer that question. Taiwan’s debut, marked by the first-ever Taiwan Excellence Pavilion at HIMSS, signals a noticeable shift–from theoretical AI to infrastructure and systems built for operational reality.
Themed “From Taiwan with Care” (Booth #6035), the pavilion reflects where healthcare technology is moving now – built for integration into existing systems, supporting clinicians and scaling across diverse care settings.
Within the pavilion, 11 exhibiting companies collectively demonstrate what that operational focus looks like in practice: dependable performance, engineering built for clinical reality, and innovation that enters production without friction.
This matters at a time when Taiwan-US medical collaboration is deepening. These solutions don’t just represent individual advancements — together, they illustrate the defining technological trends shaping the next era of healthcare.
Trend #1: Infrastructure That Enables AI Where Care Happens
One of the clearest shifts at HIMSS 2026 is the move from abstract, cloud-centric AI to systems that can be deployed and operated reliably at the clinical edge. Hospitals don’t need more dashboards; they need technology that works in the OR, the ICU, the med room, the ward, and the home — places where latency, uptime, and infection control matter more than theoretical model performance.
Taiwan’s companies have been building for this reality for years, in AI software and medical-grade computing storage, and device platforms that allow AI and digital workflows to function reliably at the point of care.
Five of these companies — Wincomm, ADLINK, Axiomtek, IEI, and Transcend — represent the infrastructure layer behind modern clinical AI — medical-grade PCs, edge AI systems, panel PCs, and industrial-grade storage that make real-time inference possible where care is delivered.
- Wincomm: Mobile point-of-care PCs with hot-swappable batteries that keep nursing workflows uninterrupted.
- ADLINK: FDA-listed OR/ICU panel PCs delivering deterministic performance for imaging and on-device AI.
- Axiomtek: The modular mBOX600 extends hardware lifespan by 1.5× and cuts e-waste by 40%.
- IEI: The HTB-300-MTLH uses Intel® Core
Ultra processors with built-in NPUs for low-power AI inference.
- Transcend: SSDs engineered for power-loss protection and extreme-temperature resilience.
If buzzwords are the headline, edge-ready systems determine whether AI survives inside the hospital.
Trend #2: The End of the Pilot Era
For a decade, U.S. health systems have struggled to move beyond pilots. Many initiatives fail because they demand extensive integration, significant training, or disruptive changes to already strained workflows.
Health systems are increasingly prioritizing technologies that can align with existing IT architecture rather than requiring wholesale redesign. Taiwan’s approach reflects this evolution, a focus on systems designed to work on day one.
- Imedtac’s iMADC-Lite: A medication management system requiring no HIS integration, using secure ID verification, and automating dispensing and inventory. It’s plug-and-use — a phrase every CIO wishes they heard more often.
- SURGLASSES’ Caduceus S: An AR surgical navigation system that overlays anatomical structures, trajectories, and risk zones directly onto the patient, reducing the need for surgeons to shift attention between operating field and external monitors.
- tst biomedical’s iProtin Lp(a) test: A point-of-care cardiovascular risk test that brings one of cardiology’s most important biomarkers out of the lab and into everyday care, supporting earlier risk stratification during routine clinical visits.
Trend #3: Diagnostics Are Finally Catching Up to the Rest of Healthcare
Diagnostics has long been the slowest-moving part of the health IT ecosystem — fragmented, manual, and dependent on specialist interpretation. Taiwan’s companies are attacking this head-on.
- AmCad BioMed: Rapid obstructive sleep apnea screening with a 10-minute, awake, non-invasive assessment and thyroid nodule detection with real-time TIRADS reporting, aimed at accelerating clinical decision-marking within standard appointment windows.
- Zinexts Life Science: A high‑plex molecular testing platform paired with AI‑driven analysis that enables faster results and clearer insights, reducing manual processing steps while improving turnaround time for precision diagnostics.
Trend #4: Telehealth Is Moving Beyond Video Calls
With workforce shortages straining U.S. care delivery, video visits alone are no longer enough to manage rising chronic‑care demands. In Taiwan, engineers are turning remote care tools into edge‑AI systems that act as a clinician’s eyes and ears — detecting early signs of deterioration and supporting earlier intervention.
- Endosemio: Digital otoscope and ultra-slim laryngoscope systems which bring clinical‑grade visualization into virtual care, allowing providers to obtain diagnostic-quality imagery during remote consultations.
As access challenges intensify, Taiwan’s remote patient monitoring ecosystem strengthens U.S. care capacity exactly when health systems need support most.
Trend #5: Sustainability Is Becoming a Clinical Requirement
Hospitals are under pressure to reduce waste, extend hardware life, and meet ESG goals without compromising performance.
- Axiomtek’s mBOX600: A modular edge platform that extends hardware lifespan by 1.5× and reduces e-waste by 40%, helping large health systems lower capital refresh cycles while improving environmental performance metrics.
Why Taiwan, and Why Now?
The U.S. and Taiwan share one of the closest medical technology trade relationships in the world, with more than US$2.3 billion in annual device trade between the two markets. The U.S. now accounts for a quarter of Taiwan’s nearly billion‑dollar medical device exports, and collaboration is accelerating.
Taiwan’s growing medical technology leadership is becoming a strategic advantage as health systems digitize care and reinforce supply chain resilience. At HIMSS 2026, Taiwan Excellence companies showcase AI diagnostics, AR surgical tools, cardiovascular point‑of‑care testing, smart medication systems, and medical‑grade computing already used worldwide. With U.S. providers strained by labor shortages and rising remote‑care demands, Taiwan’s Bio ICT strengths offer scalable solutions.
Amid geopolitical tensions and diversified regional manufacturing strategy shifts, Taiwan provides reliable, FDA‑aligned production standards and established global supply‑chain reliability.
At a moment when health systems are prioritizing integration, operational durability, and speed to value, that alignment is what the market is asking for.
Where Innovation Moves Into Production
The Taiwan Excellence Pavilion offers a concentrated view of where healthcare technology is headed – from conceptual AI to production-grade systems reshaping care delivery worldwide. The companies gathered here are moving beyond prototypes and pilots to deliver technologies built for scale, interoperability and measurable operational impact.
- AI that runs at the edge
- Diagnostics that standardize interpretation
- Telehealth that diagnoses, not just connects
- Computing infrastructure that maintains uptime under clinical load
- Sustainability built at the hardware layer
- Products that move beyond pilot without operational disruption
If HIMSS 2026 reflects an industry maturing beyond experimentation, the Taiwan Excellence Pavilion reflects that maturity in practice.
Product Launch & Boba Networking Mixer
Taiwan Excellence Pavilion HIMSS 2026
Booth #6035
March 10–12, Venetian Expo, Las Vegas
On Tuesday, March 10, the Taiwan External Trade Development Council (TAITRA), Taiwan’s foremost trade promotion organization, will host a Product Launch & Boba Networking Mixer at 1:30 p.m. in Booth #6035. Space is limited, RSVP early here.
As the healthcare community converges in Las Vegas for